MNMD - Psyched: Veterans & Psychedelics $100M IPO Cybin's $64M Offering Worldwide Events & More | Benzinga
Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?
An average of 17 veterans committed suicide per day in 2020 according to the Dept of Veterans Affairs. The percentage of veterans from conflicts in the Middle East who have experienced PTSD is nearly triple the number of those from the Vietnam War. Suicide is the second leading cause of death among veterans.
The national committee under the Veterans Affairs & Rehabilitation Commission has long advocated expanded clinical research into alternative treatments for mental health conditions like PTSD, particularly for conditions that do not respond to prescription drugs. The Veteran Mental Health Leadership Coalition and the nonprofit Reason for Hope have been looking at the science and research for the careful use of psychedelic treatments – psilocybin, ayahuasca, MDMA and ketamine to manage PTSD and reduce veteran suicide. Keep reading HERE.
This Psychedelics Co. May IPO With '$100M In Revenue' Changing Mental Health Forever, Says VC Investor
In the evolving narrative of modern medicine, there's a new chapter being written by the pioneers at the helm of Mystic Ventures, where managing partner Jeremy Gardner is intently focused on the profound potential of psychedelics. The latest developments in this arena are not just about a burgeoning industry, but a seismic shift in how we approach some of the most intractable mental health issues.
"There's never been a more exciting time to be doing what we're doing," Gardner states, his voice resonating with the kind of conviction that only comes when one's work aligns seamlessly with one's values. At the age of 31, having already navigated multiple careers, Gardner has found his calling in the psychedelic space, an industry ...